159783-04-7

Basic information

• Product Name: Benzaldehyde, 3-(cyclopentyloxy)-4-(phenylmethoxy)-
• CAS NO: 159783-04-7
• Molecular Formula: C19H20O3
• Molecular Weight: 296.366
• Mol File: 159783-04-7.mol

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 3-(cyclopentyloxy)-4-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3-(cyclopentyloxy)-4-(phenylmethoxy)-(159783-04-7)
• EPA Substance Registry System: Benzaldehyde, 3-(cyclopentyloxy)-4-(phenylmethoxy)-(159783-04-7)

Safety Data

• Hazardous Substances Data: 159783-04-7(Hazardous Substances Data)

Upstream product

• 137-43-9 Cyclopentyl bromide 
• 4049-39-2 4-benzyloxy-3-hydroxy-benzaldehyde 

Downstream Products

• 159783-05-8 3-cyclopentyloxy-4-benzyloxybenzoic acid 
• 686717-44-2 4-benzyl-3-[3-(4-benzyloxy-3-cyclopentyloxyphenyl)-4-nitrobutyryl]oxazolidin-2-one 

Relevant articles and documents

PYRROLIDONES WITH ANTI-HIV ACTIVITY

The present invention relates to inhibition of viruses, e.g., HIV using pyrrolidones and compounds related to pyrrolidones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhi

COMPOUNDS CONTAINING PHENYL LINKED TO ARYL OR HETEROARYL BY AN ALIPHATIC- OR HETEROATOM-CONTAINING LINKING GROUP

This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase

Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group

This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.